Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

NONINVASIVE QUANTIFICATION OF BRAIN GLUCOSE METABOLISM FOR POSITRON EMISSION TOMOGRAPHY DATA ACQUIRED WITH BOTH A PORTABLE CAMERA AND A TRADITIONAL SCANNER
Quantification of Glucose Metabolism in the Brain
Sponsor:National Institute of Biomedical Imaging and Bioengineering
Enrolling:Male and Female Patients
IRB Number:7653
Contact: Mohammad Lesanpezeshki: 6467747560 / mohammad.lesanpezeshki@nyspi.columbia.edu
Additional Study Information:

Note: Due to COVID-19, all the research procedures, except the phone screening for this study, has been on pause. The in-person screening and the research procedures will start after the pause is lifted. The purpose of this study is to examine the use of a new portable brain imaging device to study a measure of brain activity, and to develop optimal methods for analyzing the data from this device. After baseline assessments including clinical interview, physical exam, and blood tests, participants will undergo 3 brain scans on separate days: two Positron Emission Tomography (PET) scans, each lasting one hour, using different PET cameras, to measure metabolic activity in the brain, and one Magnetic Resonance Imaging (MRI) scan, to obtain information about brain structure. Participants will be compensated $250 for each of the PET scans, a $100 for the MRI scan, and $100 bonus for completing all the research procedures, so the total compensation is up to $700.

Do You Qualify?
Are you physically healthy?YesNo
Do you have any history of psychiatric illness?YesNo
Are you between the ages of 18-60 years?YesNo
Submit
Cancel
Investigator
Francesca Zanderigo, PhD
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Mohammad Lesanpezeshki
Email: mohammad.lesanpezeshki@nyspi.columbia.edu
Phone: 6467747560